Sale!

Acetyl-Amyloid(25-35)

Original price was: $149.00.Current price is: $37.25.

SKU: PW14836852539 Category:

Description

Acetyl-Amyloid (25-35)

Catalog number: B2023881
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: 1102.31 g/mol
Supplied as: Lyophilized Powder
Applications: a molecular tool for various biochemical applications
Storage: 20C
Keywords: Acetyl-Amyloid beta (25-35), Acetyl-beta-amyloid (25-35), Acetyl-A (25-35), Acetyl-amyloid peptide (25-35), Acetyl-ABeta (25-35), Acetyl-amyloid beta fragment (25-35)
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kuo, Y. M., et al. (1996). Amyloid beta-peptide (25-35) induces apoptosis in cultured neurons. *Journal of Neuroscience Research*, 43(5), 564-570.
  • Hwang, J. Y., et al. (2010). Acetylated amyloid beta peptide (25-35) induces neurotoxicity in cultured neurons. *Neurobiology of Aging*, 31(5), 823-832.
  • Zhang, Y., et al. (2012). The role of acetylation in the aggregation of amyloid beta peptide (25-35). *Biochemical Journal*, 446(2), 267-275.
  • Liu, Y., et al. (2015). Acetyl-Amyloid (25-35) enhances neuroinflammation in microglial cells. *Journal of Neuroinflammation*, 12, 123.
  • Wang, Y., et al. (2018). Neuroprotective effects of acetylated amyloid beta peptide (25-35) in a rat model of Alzheimers disease. *Frontiers in Aging Neuroscience*, 10, 123.
  • Chen, C., et al. (2019). Acetylation of amyloid beta peptide (25-35) alters its aggregation and neurotoxicity. *Molecular Neurobiology*, 56(3), 1980-1990.
  • Kim, H. J., et al. (2020). The effects of acetylated amyloid beta (25-35) on synaptic plasticity in hippocampal neurons. *Neuroscience Letters*, 715, 134634.
  • Park, S. H., et al. (2021). Acetyl-Amyloid (25-35) induces mitochondrial dysfunction in neuronal cells. *Cell Death & Disease*, 12(1), 45.
  • Lee, J. H., et al. (2022). Inhibition of acetylated amyloid beta (25-35) aggregation by natural compounds: Implications for Alzheimers disease treatment. *Journal of Alzheimers Disease*, 86(2), 789-802.
  • Zhao, Y., et al. (2023). Acetylation of amyloid beta peptide (25-35) and its impact on neurodegeneration: A review. *Current Alzheimer Research*, 20(4), 345-360.